Miet Peeters
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State.
Journal: Dermatology and therapy
Published: January 12, 2024
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 23, 2020
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
Journal: Journal of clinical gastroenterology
Published: December 03, 2019
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time.
Journal: Inflammatory bowel diseases
Published: November 16, 2017
Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
Journal: Stroke
Published: May 18, 2016
Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against Etanercept.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 09, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
Journal: Inflammatory bowel diseases
Published: August 28, 2015
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.
Journal: Inflammatory bowel diseases
Published: February 07, 2015
Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization.
Journal: Therapeutic drug monitoring
Published: June 07, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026